ViviCells Total Current Liabilities from 2010 to 2026
| VCII Stock | USD 0.0001 0.00 0.000003% |
Total Current Liabilities | First Reported 2010-12-31 | Previous Quarter 780.4 K | Current Value 684.1 K | Quarterly Volatility 38.1 K |
Check ViviCells International financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ViviCells International's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 820 K, as well as many indicators such as Price To Sales Ratio of 17.1 K, Dividend Yield of 0.0 or PTB Ratio of 6.49. ViviCells financial statements analysis is a perfect complement when working with ViviCells International Valuation or Volatility modules.
ViviCells | Total Current Liabilities | Build AI portfolio with ViviCells Stock |
The Total Current Liabilities trend for ViviCells International offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether ViviCells International is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest ViviCells International's Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of ViviCells International over the last few years. Total Current Liabilities is an item on ViviCells International balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of ViviCells International are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. ViviCells International's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ViviCells International's overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
ViviCells Total Current Liabilities Regression Statistics
| Arithmetic Mean | 678,224 | |
| Geometric Mean | 677,187 | |
| Coefficient Of Variation | 5.62 | |
| Mean Deviation | 13,298 | |
| Median | 678,584 | |
| Standard Deviation | 38,118 | |
| Sample Variance | 1.5B | |
| Range | 215.2K | |
| R-Value | 0.54 | |
| Mean Square Error | 1.1B | |
| R-Squared | 0.29 | |
| Significance | 0.03 | |
| Slope | 4,077 | |
| Total Sum of Squares | 23.2B |
ViviCells Total Current Liabilities History
About ViviCells International Financial Statements
Investors use fundamental indicators, such as ViviCells International's Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although ViviCells International's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 780.4 K | 684.1 K |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of ViviCells International Correlation against competitors. For more detail on how to invest in ViviCells Stock please use our How to Invest in ViviCells International guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is there potential for Independent Power and Renewable Electricity Producers market expansion? Will ViviCells introduce new products? Factors like these will boost the valuation of ViviCells International. If investors know ViviCells will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about ViviCells International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Revenue Growth (0.27) |
ViviCells International's market price often diverges from its book value, the accounting figure shown on ViviCells's balance sheet. Smart investors calculate ViviCells International's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since ViviCells International's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between ViviCells International's value and its price as these two are different measures arrived at by different means. Investors typically determine if ViviCells International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ViviCells International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.